MX9306005A - IBUPROPEN-CAFEINE COMBINATIONS. - Google Patents
IBUPROPEN-CAFEINE COMBINATIONS.Info
- Publication number
- MX9306005A MX9306005A MX9306005A MX9306005A MX9306005A MX 9306005 A MX9306005 A MX 9306005A MX 9306005 A MX9306005 A MX 9306005A MX 9306005 A MX9306005 A MX 9306005A MX 9306005 A MX9306005 A MX 9306005A
- Authority
- MX
- Mexico
- Prior art keywords
- ibuprofen
- ibupropen
- cafeine
- combinations
- lisin
- Prior art date
Links
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- HEFNNWSXXWATRW-JTQLQIEISA-N dexibuprofen Chemical class CC(C)CC1=CC=C([C@H](C)C(O)=O)C=C1 HEFNNWSXXWATRW-JTQLQIEISA-N 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- HEFNNWSXXWATRW-SNVBAGLBSA-N levibuprofen Chemical compound CC(C)CC1=CC=C([C@@H](C)C(O)=O)C=C1 HEFNNWSXXWATRW-SNVBAGLBSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a composiciones farmacéuticas para el uso en eltratamiento de dolor e inflamación de mamíferos, incluyendo humanos aladministrar composiciones que comprenden (i) una cantidad analgésica yanti-inflamatoria de una sal de (S)-ibuprofeno substancialmente libre de(R)-ibuprofeno en las cuales la sal se selecciona de(S)-ibuprofenm-(S)-lisina y (S-ibuprofen-(R)-lisina; y (ii) una cantidad efectiva en elaumento del alivio del dolor de la cafeína.The invention relates to pharmaceutical compositions for use in the treatment of mammalian pain and inflammation, including humans to administer compositions comprising (i) an analgesic and anti-inflammatory amount of a (S) -ibuprofen salt substantially free of (R) - ibuprofen in which the salt is selected from (S) -ibuprofenm- (S) -lisin and (S-ibuprofen- (R) -lisin; and (ii) an effective amount in increasing caffeine pain relief.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95342392A | 1992-09-29 | 1992-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9306005A true MX9306005A (en) | 1995-01-31 |
Family
ID=25493974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9306005A MX9306005A (en) | 1992-09-29 | 1993-09-28 | IBUPROPEN-CAFEINE COMBINATIONS. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0663819A4 (en) |
| JP (1) | JPH08501796A (en) |
| AU (1) | AU5132893A (en) |
| CA (1) | CA2144152A1 (en) |
| MX (1) | MX9306005A (en) |
| WO (1) | WO1994007471A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE151740T1 (en) * | 1992-12-02 | 1997-05-15 | Knoll Ag | METHOD FOR PRODUCING ESSENTIAL ENANTIOMERS OF PHENYLPROPIONIC ACIDS |
| EP0717624A1 (en) * | 1993-09-07 | 1996-06-26 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
| JPH0987174A (en) * | 1995-09-26 | 1997-03-31 | Kobayashi Pharmaceut Co Ltd | Analgesic and anti-inflammatory composition |
| US6251945B1 (en) * | 1999-01-14 | 2001-06-26 | Knoll Aktiengesellschaft | Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| US20090238763A1 (en) * | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
| CA2958454A1 (en) * | 2014-08-28 | 2016-03-03 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition for the treatment of acute tooth or jaw pain |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4420483A (en) * | 1982-07-22 | 1983-12-13 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same |
| US4558051A (en) * | 1983-10-11 | 1985-12-10 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same |
| US4681897A (en) * | 1984-01-16 | 1987-07-21 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
| WO1992005783A1 (en) * | 1990-09-28 | 1992-04-16 | Merck & Co., Inc. | Ibuprofen-antihistamine combinations |
-
1993
- 1993-09-21 JP JP6509126A patent/JPH08501796A/en active Pending
- 1993-09-21 WO PCT/US1993/008896 patent/WO1994007471A1/en not_active Ceased
- 1993-09-21 CA CA002144152A patent/CA2144152A1/en not_active Abandoned
- 1993-09-21 AU AU51328/93A patent/AU5132893A/en not_active Abandoned
- 1993-09-21 EP EP93922264A patent/EP0663819A4/en not_active Withdrawn
- 1993-09-28 MX MX9306005A patent/MX9306005A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0663819A4 (en) | 1998-05-27 |
| WO1994007471A1 (en) | 1994-04-14 |
| JPH08501796A (en) | 1996-02-27 |
| EP0663819A1 (en) | 1995-07-26 |
| CA2144152A1 (en) | 1994-04-14 |
| AU5132893A (en) | 1994-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2156839T1 (en) | MEDICINAL CONTAINING ALGINATE AND IMPLANT TO TREAT FIBROSIS. | |
| ES2086270T5 (en) | METABOLITES OF TERFENADINE AND ITS OPTICALLY PURE ISOMERS TO TREAT ALLERGIC DISORDERS. | |
| ES2072447T3 (en) | EXTERNAL ANALGESIC LOTION AND PREPARATION PROCEDURE. | |
| MX9301929A (en) | DERIVATIVES OF PIRIMIDINE AND PROCEDURES FOR ITS PREPARATION. | |
| ES2139132T3 (en) | PHARMACEUTICAL COMPOSITIONS ACTIVE IN SLEEP DISORDERS THERAPY. | |
| BR9406979A (en) | Compound, pharmaceutical composition for treating an inflammatory disease susceptible to treatment with a non-steroidal anti-inflammatory agent processes for treating an inflammatory disease and for preparing a pharmaceutically acceptable salt compound use of a non-steroidal anti-inflammatory pharmaceutical composition compound | |
| AR003938A1 (en) | TRICYCLIC UREA COMPOUNDS USEFUL FOR THE INHIBITION OF THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROTEOLYTIC DISEASES, PHARMACEUTICAL COMPOSITION, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES. | |
| DK0607128T4 (en) | Drugs and their manufacture and use in the control of pain and / or inflammation in animals and humans | |
| ES2082288T3 (en) | THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLACO. | |
| ES2165997T3 (en) | USE OF A PEDIATRIC PHARMACEUTICAL FORMULATION THAT INCLUDES AMOXYCLINE AND CLAVULANATE. | |
| ES2059965T3 (en) | A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY DISEASES. | |
| ES2169197T3 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ALCANOIL L-CARNITINE IN COMBINATION WITH A POLYINSATURED FATTY ACID OF THE OMEGA-3 SERIES FOR THE PREVENTION AND TREATMENT OF LIPID METABOLISM DISORDERS. | |
| BR9406363A (en) | Pharmaceutical composition process for the preparation of the same use and process for the treatment of diseases related to gastric acid | |
| ES2075202T3 (en) | NEW ARILPIRIDAZINES, THEIR PREPARATION, THEIR USE, AND THE MEDICINES THAT CONTAIN THEM. | |
| ES2128791T3 (en) | SPIROCETAL DERIVATIVES, COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS THERAPEUTIC AGENTS. | |
| MX9304564A (en) | COMBINATIONS OF MUSCLE RELAXANT-IBUPROFEN. | |
| ES2100046T3 (en) | ANTIPIRETIC AND ANALGESIC COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLACO. | |
| ES2130152T3 (en) | MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE. | |
| ATE15596T1 (en) | PHARMACEUTICAL AGENT. | |
| RU94002337A (en) | Pharmaceutical composition, use of gamma-linolenic acid or dihomo-gamma-linolenic acid for damage treatment after irradiation, treatment method | |
| IT1170214B (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES | |
| DK165903C (en) | PHARMACEUTICAL PREPARATION AGAINST ACNE | |
| AR004052A1 (en) | A COSMETIC OR PHARMACEUTICAL COMPOSITION INCLUDING A BETA-ADRENERGIC AGONIST | |
| IT1282736B1 (en) | USE OF P-AMINOPHENOL DERIVATIVES TO PREPARE PHARMACEUTICAL COMPOSITIONS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| MX9306005A (en) | IBUPROPEN-CAFEINE COMBINATIONS. |